Cytoimmune Biologics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1M
- Investors
-
2
Cytoimmune Biologics General Information
Description
Developer of an integrated ecosystem of biologic and cell therapy technologies and capabilities designed to commercialise a wide range of regenerative medicines. The company's platform offers a focused approach to differentiated technologies and research & development efforts, including a clinical cell manufacturing facility tailored to support the advancement and commercialisation of innovative NK cell therapies, enabling partners such as researchers, medical professionals, and biotech companies to access cell therapy and enhance the well-being of cancer patients.
Contact Information
Website
www.cytoimmunebiologics.comCorporate Office
- 845 Meridian Street
- Duarte, CA 91010
- United States
Corporate Office
- 845 Meridian Street
- Duarte, CA 91010
- United States
Cytoimmune Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Jan-2023 | $1M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | 06-Aug-2021 | Completed | Pre-Clinical Trials |
Cytoimmune Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cytoimmune Biologics Patents
Cytoimmune Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023034758-A1 | Methods and compositions for cell expansion | Inactive | 30-Aug-2021 | ||
| WO-2023278335-A1 | Methods and compositions for cell expansion | Inactive | 28-Jun-2021 | ||
| WO-2022240808-A1 | Methodsand compositions for efficiently expanding cord blood nk cells | Inactive | 11-May-2021 | ||
| JP-2023540997-A | Methods and compositions for infecting, activating, and expanding immune cells | Pending | 08-Sep-2020 | ||
| AU-2021341944-A1 | Methods and compositions of infecting, activating, and expanding immune cells | Inactive | 08-Sep-2020 | A61K40/15 |
Cytoimmune Biologics Signals
Cytoimmune Biologics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Myeloma Investment Fund | Not-For-Profit Venture Capital | Minority | ||
| Sofinnova Partners | Venture Capital | Minority |
Cytoimmune Biologics Investments (1)
Cytoimmune Biologics’s most recent deal was a PIPE with Hemostemix for . The deal was made on 04-Feb-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hemostemix | 04-Feb-2025 | PIPE | Biotechnology |
Cytoimmune Biologics FAQs
-
When was Cytoimmune Biologics founded?
Cytoimmune Biologics was founded in 2017.
-
Where is Cytoimmune Biologics headquartered?
Cytoimmune Biologics is headquartered in Duarte, CA.
-
What is the size of Cytoimmune Biologics?
Cytoimmune Biologics has 40 total employees.
-
What industry is Cytoimmune Biologics in?
Cytoimmune Biologics’s primary industry is Drug Discovery.
-
Is Cytoimmune Biologics a private or public company?
Cytoimmune Biologics is a Private company.
-
What is Cytoimmune Biologics’s current revenue?
The current revenue for Cytoimmune Biologics is .
-
How much funding has Cytoimmune Biologics raised over time?
Cytoimmune Biologics has raised $37.5M.
-
Who are Cytoimmune Biologics’s investors?
Myeloma Investment Fund and Sofinnova Partners have invested in Cytoimmune Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process